Two-Pronged attack on cancer in the brain: experimental combo aims to shrink tumors
NCT ID NCT05700721
Summary
This study is testing whether combining two existing cancer drugs, niraparib and dostarlimab, can help control advanced cancers that have spread to the brain. It will enroll 120 adults with specific types of cancer, including lung and breast cancer, who have active, growing brain tumors. The main goal is to see if this drug combination can shrink or stop the growth of these brain metastases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.